Early Detection of Type 1 Diabetes in First-Degree Relatives in Saudi Arabia (VISION-T1D): Protocol for a Pilot Implementation Study (Preprint)
Authors:
- Iman S AlgadiIAIman S Algadi
- Yazed AlRuthiaYAYazed AlRuthia
- Muhammad H MujammamiMMMuhammad H Mujammami
- Khaled Hani AburishehKhaled Hani Aburisheh
- Metib AlotaibiMAMetib Alotaibi
- Sharifah Al IssaSISharifah Al Issa
- Amal A Al-SaifAAAmal A Al-Saif
- David SeftelDSDavid Seftel
- Cheng-Ting TsaiCTCheng-Ting Tsai
- Reem A Al KhalifahRKReem A Al Khalifah
Preprint
- 25 December 2024
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Type 1 diabetes (T1D) is a growing global health concern, with a notable rise in incidence in Saudi Arabia. Despite the potential benefits of early detection through screening programs, such initiatives are currently lacking in Saudi Arabia and other Arab countries. OBJECTIVE This study aims to evaluate the feasibility, acceptability, and cost-effectiveness of a T1D-screening program targeting high-risk individuals, specifically children with a first-degree relative diagnosed with T1D. METHODS The VISION-T1D program is a prospective cohort study focused on the early detection of presymptomatic T1D by screening children aged 2-18 years. The primary screening method involves testing for islet autoantibodies, including insulin autoantibodies, glutamic acid decarboxylase autoantibodies, insulinoma associated-2 autoantibodies, and zinc transporter-8 autoantibodies. Optional genetic testing, including human leukocyte antigen phenotyping and the genetic risk score, is offered. Outcomes include the feasibility of the screening process, prevalence of early-stage T1D, psychological impacts, educational intervention effectiveness, progression rates to stage-3 T1D, and economic viability. RESULTS The VISION-T1D program began in May 2024. As of December 2024, a total of 176 families have been enrolled. Data collection will continue until April 2025, with final data analysis projected for mid-2025. CONCLUSIONS The VISION-T1D study provides a practical approach to T1D screening tailored to the health care landscape of Saudi Arabia. The insights gained from this pilot program will inform the development of a national, population-based screening initiative designed to reduce diabetic ketoacidosis at diagnosis, improve long-term outcomes, and alleviate the economic burden of T1D. The VISION-T1D initiative could also serve as a scalable and sustainable model that can be adopted internationally, contributing to global efforts to manage and prevent T1D. CLINICALTRIAL ClinicalTrials.gov NCT06513247; https://clinicaltrials.gov/study/NCT06513247 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/70575Keywords
All Related Versions
- Published version: JMIR Research Protocols, 14, e70575.
This publication has 48 references indexed in Scilit:
- Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assaysEBioMedicine, 2024
- Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetesDiabetes/Metabolism Research and Reviews, 2024
- Utility of genetic risk scores in type 1 diabetesDiabetologia, 2023
- Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among ChildrenJAMA Network Open, 2022
- Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th editionDiabetes Research and Clinical Practice, 2022
- Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continentsDiabetologia, 2020
- Type 1 diabetes, quality of life, occupational status and education level – A comparative population-based studyDiabetes Research and Clinical Practice, 2016
- Validity of Global Physical and Emotional SUDSApplied Psychophysiology and Biofeedback, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-AnalysisJournal of General Internal Medicine, 2007